These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16447768)

  • 1. [Mutational and clinical features of Japanese patients with dysferlinopathy (Miyoshi myopathy and limb girdle muscular dystrophy type 2B)].
    Aoki M; Takahashi T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):938-42. PubMed ID: 16447768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysferlin mutations in Japanese Miyoshi myopathy: relationship to phenotype.
    Takahashi T; Aoki M; Tateyama M; Kondo E; Mizuno T; Onodera Y; Takano R; Kawai H; Kamakura K; Mochizuki H; Shizuka-Ikeda M; Nakagawa M; Yoshida Y; Akanuma J; Hoshino K; Saito H; Nishizawa M; Kato S; Saito K; Miyachi T; Yamashita H; Kawai M; Matsumura T; Kuzuhara S; Ibi T; Sahashi K; Nakai H; Kohnosu T; Nonaka I; Arahata K; Brown RH; Saito H; Itoyama Y
    Neurology; 2003 Jun; 60(11):1799-804. PubMed ID: 12796534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysferlinopathy: a clinical and histopathological study of 28 patients from India.
    Nalini A; Gayathri N
    Neurol India; 2008; 56(3):379-85; discussion 386-7. PubMed ID: 18974568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B.
    Takahashi T; Aoki M; Suzuki N; Tateyama M; Yaginuma C; Sato H; Hayasaka M; Sugawara H; Ito M; Abe-Kondo E; Shimakura N; Ibi T; Kuru S; Wakayama T; Sobue G; Fujii N; Saito T; Matsumura T; Funakawa I; Mukai E; Kawanami T; Morita M; Yamazaki M; Hasegawa T; Shimizu J; Tsuji S; Kuzuhara S; Tanaka H; Yoshioka M; Konno H; Onodera H; Itoyama Y
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):433-40. PubMed ID: 23243261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.
    Nguyen K; Bassez G; Krahn M; Bernard R; Laforêt P; Labelle V; Urtizberea JA; Figarella-Branger D; Romero N; Attarian S; Leturcq F; Pouget J; Lévy N; Eymard B
    Arch Neurol; 2007 Aug; 64(8):1176-82. PubMed ID: 17698709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysferlin protein analysis in limb-girdle muscular dystrophies.
    Vainzof M; Anderson LV; McNally EM; Davis DB; Faulkner G; Valle G; Moreira ES; Pavanello RC; Passos-Bueno MR; Zatz M
    J Mol Neurosci; 2001 Aug; 17(1):71-80. PubMed ID: 11665864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients.
    Tagawa K; Ogawa M; Kawabe K; Yamanaka G; Matsumura T; Goto K; Nonaka I; Nishino I; Hayashi YK
    J Neurol Sci; 2003 Jul; 211(1-2):23-8. PubMed ID: 12767493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DYSF mutation analysis in a group of Chinese patients with dysferlinopathy.
    Zhao Z; Hu J; Sakiyama Y; Okamoto Y; Higuchi I; Li N; Shen H; Takashima H
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1234-7. PubMed ID: 23254335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s).
    Weiler T; Bashir R; Anderson LV; Davison K; Moss JA; Britton S; Nylen E; Keers S; Vafiadaki E; Greenberg CR; Bushby CR; Wrogemann K
    Hum Mol Genet; 1999 May; 8(5):871-7. PubMed ID: 10196377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous characteristics of Korean patients with dysferlinopathy.
    Park HJ; Hong JM; Suh GI; Shin HY; Kim SM; Sunwoo IN; Suh BC; Choi YC
    J Korean Med Sci; 2012 Apr; 27(4):423-9. PubMed ID: 22468107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies.
    Paradas C; Llauger J; Diaz-Manera J; Rojas-García R; De Luna N; Iturriaga C; Márquez C; Usón M; Hankiewicz K; Gallardo E; Illa I
    Neurology; 2010 Jul; 75(4):316-23. PubMed ID: 20574037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysferlin mutation analysis in a group of Italian patients with limb-girdle muscular dystrophy and Miyoshi myopathy.
    Kawabe K; Goto K; Nishino I; Angelini C; Hayashi YK
    Eur J Neurol; 2004 Oct; 11(10):657-61. PubMed ID: 15469449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid screening for Japanese dysferlinopathy by fluorescent primer extension.
    Hayashi S; Ohsawa Y; Takahashi T; Suzuki N; Okada T; Rikimaru M; Murakami T; Aoki M; Sunada Y
    Intern Med; 2010; 49(24):2693-6. PubMed ID: 21173544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysferlin aggregation in limb-girdle muscular dystrophy type 2B/Miyoshi Myopathy necessitates mutational screen for diagnosis [corrected].
    Nilsson MI; Laureano ML; Saeed M; Tarnopolsky MA
    Muscle Nerve; 2013 May; 47(5):740-7. PubMed ID: 23519732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of dysferlinopathy presenting choreic movements.
    Takahashi T; Aoki M; Imai T; Yoshioka M; Konno H; Higano S; Onodera Y; Saito H; Kimura I; Itoyama Y
    Mov Disord; 2006 Sep; 21(9):1513-5. PubMed ID: 16817213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy.
    Illarioshkin SN; Ivanova-Smolenskaya IA; Greenberg CR; Nylen E; Sukhorukov VS; Poleshchuk VV; Markova ED; Wrogemann K
    Neurology; 2000 Dec; 55(12):1931-3. PubMed ID: 11134403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dysferlin expression in limb-girdle muscular dystrophy and Miyoshi myopathy: analysis of 45 cases].
    Ren SC; Yan CZ; Li MX; Liu SP; Wu JL; Zhao YY; Li W; Li DN
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1486-90. PubMed ID: 17785089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF.
    Diers A; Carl M; Stoltenburg-Didinger G; Vorgerd M; Spuler S
    Neuromuscul Disord; 2007 Feb; 17(2):157-62. PubMed ID: 17129727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New aspects on patients affected by dysferlin deficient muscular dystrophy.
    Klinge L; Aboumousa A; Eagle M; Hudson J; Sarkozy A; Vita G; Charlton R; Roberts M; Straub V; Barresi R; Lochmüller H; Bushby K
    J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):946-53. PubMed ID: 19528035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies.
    Nguyen K; Bassez G; Bernard R; Krahn M; Labelle V; Figarella-Branger D; Pouget J; Hammouda el H; Béroud C; Urtizberea A; Eymard B; Leturcq F; Lévy N
    Hum Mutat; 2005 Aug; 26(2):165. PubMed ID: 16010686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.